Medication Management for Upper GI Bleeding
For upper gastrointestinal bleeding, immediately initiate octreotide (50 mcg IV bolus followed by 50 mcg/hour continuous infusion) if variceal bleeding is suspected, and high-dose intravenous proton pump inhibitor (80 mg bolus followed by 8 mg/hour infusion) for all patients, along with prophylactic antibiotics (ceftriaxone 1 g IV daily) in cirrhotic patients. 1, 2
Algorithmic Approach to Medication Selection
Step 1: Determine if Patient Has Cirrhosis/Portal Hypertension
If cirrhosis is present or suspected:
Vasoactive drugs - Start immediately, even before endoscopy 1
Prophylactic antibiotics - Reduces mortality, infections, and rebleeding 3
Critical caveat: Recent evidence shows diminishing benefit of antibiotics in Child-Pugh A cirrhosis, and concerns exist about C. difficile infection with third-generation cephalosporins 2. However, the reduction in bacterial infections (18.8% absolute risk reduction) still supports their use 2.
Step 2: For All Upper GI Bleeding Patients (Variceal or Non-Variceal)
High-dose proton pump inhibitor therapy:
- 80 mg IV bolus followed by 8 mg/hour continuous infusion 6, 7, 8
- Start before endoscopy, but do not delay endoscopy for PPI administration 7, 9
- Continue for 72 hours post-endoscopy if high-risk stigmata are treated endoscopically 6, 8
- After 72 hours, transition to oral PPI twice daily for 14 days, then once daily 6
Alternative PPI regimens (if continuous infusion unavailable):
- Twice-daily IV bolus dosing
- Twice-daily oral high-dose PPI 8
Step 3: Pre-Endoscopy Adjunctive Medications
Erythromycin (for severe/ongoing bleeding):
- 250 mg IV given 30-120 minutes before endoscopy 7, 8
- Significantly improves visualization, reduces second-look endoscopy need
- Check QT interval before administration 4
- Alternative if unavailable: Metoclopramide IV 9
Step 4: Stop Vasoactive Drugs if Non-Variceal Source Confirmed
Once endoscopy reveals non-variceal bleeding (e.g., peptic ulcer), discontinue octreotide as it provides no benefit for non-variceal causes 1. Continue PPI therapy.
Key Medication Pitfalls to Avoid
Do NOT use H2-receptor antagonists - They are ineffective and not recommended 10, 6
Do NOT use somatostatin/octreotide for non-variceal bleeding - No benefit demonstrated 10
Do NOT use epinephrine injection as monotherapy during endoscopy - Always combine with second modality 10, 7
Do NOT delay endoscopy for PPI administration - Start PPI but proceed to endoscopy within 24 hours (within 12 hours for variceal bleeding) 7, 9
Do NOT continue antibiotics beyond 2-3 days in cirrhotic patients - Longer courses show no additional benefit and increase antibiotic resistance risk 3, 2
Do NOT stop low-dose aspirin if patient is on it for secondary cardiovascular prophylaxis - Resume immediately or within 3-5 days 8, 9
Medication Summary by Clinical Scenario
| Clinical Scenario | Medications | Duration |
|---|---|---|
| Suspected variceal bleeding | Octreotide + PPI + Ceftriaxone | 2-3 days vasoactive/antibiotics; 72h PPI infusion |
| Confirmed peptic ulcer with high-risk stigmata | PPI only (stop octreotide if started) | 72h infusion, then oral 14 days |
| Non-cirrhotic upper GI bleeding | PPI only | 72h infusion, then oral as indicated |
The most critical medication decision is recognizing cirrhosis early - this determines whether the triple therapy (vasoactive + PPI + antibiotic) versus PPI alone is needed, directly impacting mortality outcomes 1, 3.